Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.

Kudo-Saito C, Imazeki H, Nagashima K, Shoji H, Tsugaru K, Takahashi N, Kawakami T, Amanuma Y, Wakatsuki T, Okano N, Narita Y, Yamamoto Y, Kizawa R, Muro K, Boku N

Open source

DOI: 10.1007/s12672-025-03817-0
Published: 2025 Oct 22
Container: Discover oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12672-025-03817-0,
  title = {Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.},
  author = {Kudo-Saito C and Imazeki H and Nagashima K and Shoji H and Tsugaru K and Takahashi N and Kawakami T and Amanuma Y and Wakatsuki T and Okano N and Narita Y and Yamamoto Y and Kizawa R and Muro K and Boku N},
  year = {2025},
  journal = {Discover oncology},
  doi = {10.1007/s12672-025-03817-0},
  url = {https://doi.org/10.1007/s12672-025-03817-0}
}

RIS

TY  - JOUR
TI  - Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.
AU  - Kudo-Saito C
AU  - Imazeki H
AU  - Nagashima K
AU  - Shoji H
AU  - Tsugaru K
AU  - Takahashi N
AU  - Kawakami T
AU  - Amanuma Y
AU  - Wakatsuki T
AU  - Okano N
AU  - Narita Y
AU  - Yamamoto Y
AU  - Kizawa R
AU  - Muro K
AU  - Boku N
PY  - 2025
JO  - Discover oncology
DO  - 10.1007/s12672-025-03817-0
UR  - https://doi.org/10.1007/s12672-025-03817-0
ER  -

APA

C, K., H, I., K, N., H, S., K, T., N, T., T, K., Y, A., T, W., N, O., Y, N., Y, Y., R, K., K, M., & N, B. (2025). Peripheral SNCA(+) cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer.. Discover oncology. https://doi.org/10.1007/s12672-025-03817-0

Source records

pubmed · retrieved 2026-09-26T03:02:40.470Z